{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:16:40Z","timestamp":1790551000648,"version":"4.1.0"},"reference-count":26,"publisher":"Impact Journals, LLC","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,27]]},"DOI":"10.18632\/oncotarget.5196","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T21:54:23Z","timestamp":1443563663000},"page":"34245-34257","source":"Crossref","is-referenced-by-count":24,"title":["JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia"],"prefix":"10.18632","volume":"6","author":[{"given":"Alessio","family":"Montresor","sequence":"first","affiliation":[{"name":"Department of Pathology and Diagnostics, Division of General Pathology, Laboratory of Cell Trafficking and Signal Transduction, University of Verona, Verona 37134, Italy, EU"},{"name":"The Center for Biomedical Computing (CBMC), University of Verona, Verona 37134, Italy, EU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Toffali","sequence":"additional","affiliation":[{"name":"Department of Pathology and Diagnostics, Division of General Pathology, Laboratory of Cell Trafficking and Signal Transduction, University of Verona, Verona 37134, Italy, EU"},{"name":"The Center for Biomedical Computing (CBMC), University of Verona, Verona 37134, Italy, EU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Mirenda","sequence":"additional","affiliation":[{"name":"Department of Pathology and Diagnostics, Division of General Pathology, Laboratory of Cell Trafficking and Signal Transduction, University of Verona, Verona 37134, Italy, EU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Rigo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Hematology, Cancer Research & Cell Biology Laboratory, University of Verona, Verona 37134, Italy, EU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Vinante","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Hematology, Cancer Research & Cell Biology Laboratory, University of Verona, Verona 37134, Italy, EU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Laudanna","sequence":"additional","affiliation":[{"name":"Department of Pathology and Diagnostics, Division of General Pathology, Laboratory of Cell Trafficking and Signal Transduction, University of Verona, Verona 37134, Italy, EU"},{"name":"The Center for Biomedical Computing (CBMC), University of Verona, Verona 37134, Italy, EU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,9,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hon.696","article-title":"B-chronic lymphocytic leukemia: practical aspects","volume":"20","author":"Angelopoulou","year":"2002","journal-title":"Hematol Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.1989.tb04290.x","article-title":"Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture","volume":"71","author":"Kerr","year":"1989","journal-title":"Br J Haematol"},{"key":"3","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1182\/blood.V91.7.2387","article-title":"Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells","volume":"91","author":"Stryckmans","year":"1998","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Kipps","year":"2000","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.leu.2402537","article-title":"Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course","volume":"16","author":"Dohner","year":"2002","journal-title":"Leukemia"},{"key":"6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Montserrat","year":"2003","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Hamblin","year":"2003","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.346","article-title":"Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells","volume":"23","author":"Efremov","year":"2009","journal-title":"Leukemia"},{"key":"9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/leu.2013.358","article-title":"BTK inhibition targetsCLL proliferation through its effects on B-cell receptor signaling activity","volume":"28","author":"Wang","year":"2014","journal-title":"Leukemia"},{"key":"10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10428190290011921","article-title":"Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells","volume":"43","author":"Kipps","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1189\/jlb.1203652","article-title":"Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination","volume":"76","author":"Munoz","year":"2004","journal-title":"J Leukoc Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ni.1691","article-title":"Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module","volume":"10","author":"Laudanna","year":"2009","journal-title":"Nat Immunol"},{"key":"13","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1158\/0008-5472.CAN-09-2009","article-title":"Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines","volume":"69","author":"Laudanna","year":"2009","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/cbt.26607","article-title":"Role of chemokines and their receptors in chronic lymphocytic leukemia: function in microenvironment and targeted therapy","volume":"15","author":"Xu","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"15","first-page":"127","article-title":"Chemokines and the signaling modules regulating integrin affinity","volume":"3","author":"Laudanna","year":"2012","journal-title":"Front Immunol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1083\/jcb.201303067","article-title":"JAK tyrosine kinases promote hierarchical activation of Rho and Rap modules of integrin activation","volume":"203","author":"Laudanna","year":"2013","journal-title":"J Cell Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.leu.2401602","article-title":"Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)","volume":"13","author":"Kanz","year":"1999","journal-title":"Leukemia"},{"key":"18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Darnell","year":"2012","journal-title":"Immunity"},{"key":"19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Bernard","year":"1997","journal-title":"Science"},{"key":"20","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"Vainchenker","year":"2005","journal-title":"Nature"},{"key":"21","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1084\/jem.20131371","article-title":"Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F","volume":"211","author":"Skoda","year":"2014","journal-title":"J Exp Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrd3264","article-title":"Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond","volume":"10","author":"Verstovsek","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/379645a0","article-title":"Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor","volume":"379","author":"Roifman","year":"1996","journal-title":"Nature"},{"key":"24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3892\/ol.2014.2168","article-title":"JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases","volume":"8","author":"Wang","year":"2014","journal-title":"Oncol Lett"},{"key":"25","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood-2011-11-390989","article-title":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","volume":"119","author":"Spaargaren","year":"2012","journal-title":"Blood"},{"key":"26","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"Sedek","year":"2012","journal-title":"Leukemia"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T21:24:13Z","timestamp":1748640253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,10]]},"references-count":26,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2015,10,27]]}},"alternative-id":["5196","26413812"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5196","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,10]]}}}